Verified earnings results
Latigo Biotherapeutics Q3 2026 Earnings Results
Direct answer
Latigo Biotherapeutics reported Q3 2026 results on November 5, 2026.
Revenue was 0. EPS beat the estimate by 12.56%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Latigo Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 5, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -0.629
- Reported EPS
- -0.55
- Revenue
- 0
- EPS surprise
- EPS beat the estimate by 12.56%.
Explore related company data
Read the frequently asked questions.
When did Latigo Biotherapeutics report Q3 2026 earnings?
Latigo Biotherapeutics reported on November 5, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Latigo Biotherapeutics?
The verified record provides an EPS estimate of -0.629.
Has Latigo Biotherapeutics reported the Q3 2026 result?
Revenue was 0. EPS beat the estimate by 12.56%.
Which source supports this Latigo Biotherapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.